Journal
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
Volume 14, Issue 11, Pages 1248-1251Publisher
J INFECTION DEVELOPING COUNTRIES
DOI: 10.3855/jidc.13840
Keywords
COVID-19; agammaglobulinemia; convalescent plasma; IL-6 inhibitor
Categories
Ask authors/readers for more resources
We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
